Similarly, overexpression of hepatocyte growth factor-like protein (HGFL), the only known Ron ligand, and matriptase, an enzyme involved in the cleavage of pro-HGFL to produce the active ligand, are also negative prognostic factors in breast cancer [3]. This evidence concerns the gene MST1 and breast carcinoma.